The SGLT2 inhibitor Empagliflozin promotes post-stroke functional recovery in diabetic mice.

Cardiovasc Diabetol · 2024 · PMC10905950 · PMID 38424560

Europe PMC DOI

hedged sentence

0.0610

closest p · 1.2× alpha

0.0610

boldest claim

The sentences

a strong trendp = 0.061so close (0.05 < p ≤ 0.1)

Moreover, there was a strong trend towards a decreased parenchymal pericyte density in the T2D-E group compared to the T2D-VH group (p = 0.061), and no difference was detected between non-T2D and T2D-E animals (Fig. 6 e).

also in 5,725 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.